
Insights
Biologic patents - lessons on inventive step, claim drafting and infringement from Pfizer v Samsung Bioepis.
Read story

Software and AI Medical Devices in Australia: Regulatory Considerations for Technology Developers
Read story

Biologics and Biosimilars: Navigating the Patent Landscape
Read story

Data Exclusivity for Pharmaceuticals and Biologics in Australia: How Does Australia Compare?
Read story

ALDI – The Bench(mark) Bites Back
Read story

Patentability of Computer-Implemented Inventions: IP Australia Updates Guidance Following Aristocrat 25
Read story

Nalco v Cytec: Part 2 – Allowability of Claim Amendments
Read story

The Full Court's Decision in Nalco v Cytec: Part 1 – Support, Sufficiency and Claim Construction
Read story

Federal Court Grants Interlocutory Injunction in Janssen v Juno: Guidance on Patent Infringement, Validity and the Balance of Convenience
Read story

Ag-Bio Patents and the “Support” Requirement: Lessons from CSIRO v Urrbrae Foods
Read story

Federal Court Considers Offshore Performance of Patented Method Claims in Scidera v MLA
Read story
